FORMULATION AND EVALUATION OF DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 1

Abstract

The present research work is formulation and evaluation of dexlansoprazole delayed release capsules. Dexlansoprazole is proton pump inhibitor (PPI) used in treatment of gastro esophageal reflux disease (G.E.R.D), Erosive esophagitis (E.E) and acid – related factors. In this research work various polymers like HPMC P55 S, Eudragit L 100 were used as enteric coating polymers were prepared in a fluidized bed coater (FBC). The pre-formulation studies such as solubility and compatability studies were carried out. In the formulation study of dexlansoprazole different formulation (F1 - F10) have been formulated and evaluated for acid resisitance, dissolution profile and release kinetics. The drug percentage release is more when compared with the marketed product. Stability study was done at various storage conditions and months for description, assay, water content, related substances. Mainly research work is to develop a pharmaceutically equivalent low cost quality improved and stable formulation and evaluation of dexlansoprazole delayed release capsules comparable to innovator product.

Authors and Affiliations

Peer Basha Syed, Chakravarthi V,Venkateswarlu B,Koteswararao P, Farooq Ahmed

Keywords

Related Articles

Antianxiety and antioxidant profile of blue and white variety of Clitoria ternatea L

Clitoria ternatea L. (Butterfly pea; Papilionaceae) has been traditionally used in the treatment of mental disorders. But the plant has not been systematically investigated to validate its traditional claims. Thus, it...

Analytical method development and validation for the simultaneous estimation of Paracetamol and Tapentadol by RP-HPLC in bulk and pharmaceutical dosage forms

A simple rapid, accurate, precise and reproducible validated reverse phase HPLC method was developed for the determination of Paracetamol and Tapentadol in bulk and pharmaceutical dosage forms. The quantification was c...

Innovations in Nanotechnology in Water purification

A grand challenge of the 21st century is providing clean and potable water to meet human needs. By population growth, global climate change, and water quality deterioration worldwide, water supply struggles to keep up...

Development of RP-HPLC method for the simultaneous estimation of Pantoprazole and Naproxen in capsules

A new RP-HPLC method was developed for the simultaneous estimation of Naproxen and Pantoprazole in capsule dosage form. Chromatographic separation was achieved on a reversed-phase C18 column (Inertsil ODS 3V,5µ,250mm×4...

A review on implantable drug delivery system

Implantable drug delivery systems (IDDS) are an example of such systems available for therapeutics use. The major advantages of these systems contain targeted local delivery of drugs at a constant rate, fewer drugs req...

Download PDF file
  • EP ID EP33018
  • DOI -
  • Views 403
  • Downloads 0

How To Cite

Peer Basha Syed, Chakravarthi V, Venkateswarlu B, Koteswararao P, Farooq Ahmed (2013). FORMULATION AND EVALUATION OF DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES. Indian Journal of Research in Pharmacy and Biotechnology, 1(1), -. https://europub.co.uk/articles/-A-33018